Southeastern Bk Finl (SBFC) 52.5100 $SBFC South State

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Southeastern Bk Finl (SBFC) 52.5100 $SBFC

South State Corporation Announces Merger with Southeastern Bank Financial Corporation - Expands SC and GA presence
BusinessWire - Fri Jun 17, 6:00AM CDT
South State Corporation (NASDAQ:SSB) and Southeastern Bank Financial Corporation (OTCQB:SBFC) jointly announced today the signing of a definitive merger agreement. The combination of these two companies creates a premier franchise in the Carolinas and Georgia.
SSB: 74.38 (-0.41)

Southeastern Bank Financial Corp. Reports Quarterly Dividend
GlobeNewswire - Fri Apr 22, 10:07AM CDT
The Board of Directors of Southeastern Bank Financial Corp. (OTCBB:SBFC), the holding company for Georgia Bank & Trust Company of Augusta, on April 20, 2016, declared a regular quarterly cash dividend of $0.16 per share of common stock payable on May 20, 2016, to shareholders of record as of May 6, 2016.

Southeastern Bank Financial Corp. Reports Third Quarter 2015 Earnings and Declares Dividend
GlobeNewswire - Fri Oct 23, 9:00AM CDT
Southeastern Bank Financial Corp. (OTCQB:SBFC), the holding company for Georgia Bank & Trust Company of Augusta (GB&T), today reported quarterly net income of $4.87 million for the three months ended September 30, 2015, or $0.72 in diluted earnings per share, compared to $4.38 million, or $0.65 in diluted earnings per share, in the third quarter of 2014, an increase of 11.0 percent.

Southeastern Bank Financial Corp. Reports Second Quarter 2015 Earnings and Declares Dividend
GlobeNewswire - Fri Jul 24, 9:00AM CDT
Southeastern Bank Financial Corp. (OTCQB:SBFC), the holding company for Georgia Bank & Trust Company of Augusta (GB&T), today reported quarterly net income of $5.7 million for the three months ended June 30, 2015, or $0.85 in diluted earnings per share, compared to $4.0 million, or $0.60 in diluted earnings per share, in the second quarter of 2014, an increase of 40.7 percent.

Southeastern Bank Financial Corp. Reports First Quarter 2015 Earnings and Declares Dividend
GlobeNewswire - Fri Apr 24, 10:22AM CDT
Southeastern Bank Financial Corp. (OTCQB:SBFC), the holding company for Georgia Bank & Trust Company of Augusta (GB&T), today reported quarterly net income of $4.2 million for the three months ended March 31, 2015, or $0.63 in diluted earnings per share, compared to $3.8 million, or $0.57 in diluted earnings per share, in the first quarter of 2014, an increase of 10.5 percent.

Southeastern Bank Financial Corp. Reports Record Earnings for the Fourth Quarter and Year-end 2014 and Increase in Dividend
GlobeNewswire - Fri Jan 30, 9:40AM CST
Southeastern Bank Financial Corp. (OTCQB:SBFC), the holding company for Georgia Bank & Trust Company of Augusta (GB&T), today reported record quarterly net income of $4.4 million for the three months ended Dec. 31, 2014, or $0.66 in diluted earnings per share, compared to $4.4 million, or $0.65 in diluted earnings per share, in the fourth quarter of 2013. For the full year, the company reported record net income of $16.6 million, or $2.49 per diluted share, compared to net income of $16.3 million, or $2.45 per diluted share, for 2013.

Southeastern Bank Financial Corp. Reports Record Third Quarter Earnings and Declares Quarterly Dividend
GlobeNewswire - Fri Oct 31, 9:00AM CDT
Southeastern Bank Financial Corp. (OTCQB:SBFC), the holding company for Georgia Bank & Trust Company of Augusta, today reported record quarterly net income of $4.4 million for the three months ended Sept. 30, 2014, or $0.65 in diluted earnings per share, compared to $4.2 million, or $0.63 in diluted earnings per share, in the third quarter of 2013.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Insights from the New First Presidency on Global Challenges

Updated Category News Views 218

A Historic Conversation with the First Presidency The recent interview featuring the new First Presidency of The Church of Jesus Christ of Latter-day Saints marks an exciting milestone. Conducted by the talented Jane Clayson Johnson, this unique dialogue sheds light on pressing issues within the Church and broader society. It was their first public discussion, making it a...

Continue Reading
Major Bets on Donald Trump's Election Surge Past $52 Million

Updated Category News Views 119

Significant Bets on Trump's Electoral Success A trader on Polymarket, operating under the alias Fredi9999, alongside four other accounts, has made headlines recently by placing enormous bets on Donald Trump’s electoral prospects. This activity has generated considerable chatter among traders in the market. Tracking Trump's Betting Activity Harry Crane, a statistics...

Continue Reading
FMC Corporation Faces Lawsuit Over Securities Violations

Updated Category News Views 190

FMC Corporation Faces Lawsuit Over Securities Violations Recently, the Gross Law Firm has alerted shareholders of FMC Corporation (NYSE: FMC) regarding significant legal developments. This lawsuit brings attention to serious allegations concerning the company's conduct during a specific class period. Shareholder Engagement and Participation Shareholders who purchased FMC...

Continue Reading
Insider Buying at Optima Health Signals Confidence in Future Growth

Updated Category News Views 132

Insightful Insider Share Purchase at Optima Health Optima Health plc (AIM: OPT), a leading provider of corporate health and wellbeing solutions in the UK, recently announced an important transaction involving one of its key insiders. Joanne Newey, who takes on the role of Group Business Development & Propositions Director and is also a Person Discharging Managerial...

Continue Reading
Outlook Therapeutics Prepares for Upcoming Investor Interaction

Updated Category News Views 78

Outlook Therapeutics Connects with Investors at Upcoming Virtual Event ISELIN, N.J. — Outlook Therapeutics, Inc. (Nasdaq: OTLK) has been making waves in the biopharmaceutical field with its groundbreaking ocular therapy. This marks an exciting era for the company following the recent approval of its eye treatment formulation of bevacizumab, which targets wet age-related...

Continue Reading